心力衰竭风险分层中肥胖指标的研究进展与 临床应用展望
Research Advances and Clinical Application Perspectives of Obesity Indicators in Heart Failure Risk Stratification
DOI: 10.12677/acm.2026.163991, PDF,   
作者: 王 鑫：中国医学科学院，北京协和医学院，中日友好医院(中日友好临床医学研究所)，北京；任景怡*：中日友好医院心衰中心，北京
关键词: 心力衰竭；风险评估；肥胖指标；身体成分；内脏脂肪；Heart Failure； Risk Assessment； Obesity Indicators； Body Composition； Visceral Adipose Tissue
摘要: 心力衰竭(HF)的精准风险分层是改善患者预后的关键。传统体重指数(BMI)因无法区分脂肪与肌肉，评估价值有限。目前研究重点已转向能反映脂肪分布、身体成分及代谢状态的多元指标，包括中心性肥胖测量指标、影像学及生物电阻抗评估的身体成分参数、以及复合代谢指标。这些指标在预测心衰发生、发展及预后方面展现出重要价值。本文旨在系统盘点用于心力衰竭风险分层的各类肥胖指标，综述其研究进展并探讨临床应用方向。
Abstract: Accurate risk stratification in heart failure (HF) is crucial for improving patient outcomes. The traditional body mass index (BMI) has limited predictive value as it cannot distinguish between fat and muscle mass. Current research focus has shifted toward multivariate indicators that reflect fat distribution, body composition, and metabolic status, including measures of central obesity, body composition parameters assessed via imaging techniques and bioelectrical impedance analysis, as well as composite metabolic indices. These indicators have demonstrated significant value in predicting the onset, progression, and prognosis of HF. This review aims to systematically summarize various obesity-related indicators used in HF risk stratification, outline recent research advances, and discuss their potential clinical applications.
文章引用：王鑫, 任景怡. 心力衰竭风险分层中肥胖指标的研究进展与 临床应用展望[J]. 临床医学进展, 2026, 16(3): 2028-2033. https://doi.org/10.12677/acm.2026.163991

参考文献

[1] Rosano, G.M.C., Seferovic, P., Savarese, G., Spoletini, I., Lopatin, Y., Gustafsson, F., et al. (2022) Impact Analysis of Heart Failure across European Countries: An ESC-HFA Position Paper. ESC Heart Failure, 9, 2767-2778. [Google Scholar] [CrossRef] [PubMed]
[2] Neeland, I.J., Poirier, P. and Després, J. (2018) Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management. Circulation. Circulation, 137, 1391-1406. [Google Scholar] [CrossRef] [PubMed]
[3] Powell-Wiley, T.M., Poirier, P., Burke, L.E., Després, J., Gordon-Larsen, P., Lavie, C.J., et al. (2021) Obesity and Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation, 143, e984-e1010. [Google Scholar] [CrossRef] [PubMed]
[4] Billingsley, H.E., Del Buono, M.G., Canada, J.M., Kim, Y., Damonte, J.I., Trankle, C.R., et al. (2022) Sarcopenic Obesity Is Associated with Reduced Cardiorespiratory Fitness Compared with Nonsarcopenic Obesity in Patients with Heart Failure with Reduced Ejection Fraction. Circulation: Heart Failure, 15, e009518. [Google Scholar] [CrossRef] [PubMed]
[5] Khan, S.S., Ning, H., Wilkins, J.T., Allen, N., Carnethon, M., Berry, J.D., et al. (2018) Association of Body Mass Index with Lifetime Risk of Cardiovascular Disease and Compression of Morbidity. JAMA Cardiology, 3, Article 280. [Google Scholar] [CrossRef] [PubMed]
[6] Kaze, A.D., Erqou, S., Santhanam, P., Bertoni, A.G., Ahima, R.S., Fonarow, G.C., et al. (2022) Variability of Adiposity Indices and Incident Heart Failure among Adults with Type 2 Diabetes. Cardiovascular Diabetology, 21, Article No. 16. [Google Scholar] [CrossRef] [PubMed]
[7] Streng, K.W., Voors, A.A., Hillege, H.L., Anker, S.D., Cleland, J.G., Dickstein, K., et al. (2018) Waist-to-Hip Ratio and Mortality in Heart Failure. European Journal of Heart Failure, 20, 1269-1277. [Google Scholar] [CrossRef] [PubMed]
[8] Ichikawa, T., Okada, H., Nakajima, H., Yoneda, M., Ushigome, E., Hamaguchi, M., et al. (2025) Anthropometric Indices for Predicting Incident Cardiovascular Disease: A 13-Year Follow-Up Study in a Japanese Population. The American Journal of Clinical Nutrition, 122, 954-961. [Google Scholar] [CrossRef] [PubMed]
[9] Wu, Z., Huang, Z., Sun, L., Fu, Y., Chen, S., Wu, S., et al. (2024) Neck Circumference, Waist-to-Height Ratio, Chinese Visceral Adiposity Index and Incident Heart Failure. Nutrition Journal, 23, Article No. 149. [Google Scholar] [CrossRef] [PubMed]
[10] Kamiya, K., Masuda, T., Matsue, Y., Inomata, T., Hamazaki, N., Matsuzawa, R., et al. (2016) Complementary Role of Arm Circumference to Body Mass Index in Risk Stratification in Heart Failure. JACC: Heart Failure, 4, 265-273. [Google Scholar] [CrossRef] [PubMed]
[11] Ostrominski, J.W., Højbjerg Lassen, M.C., Butt, J.H., Claggett, B.L., Anand, I.S., Desai, A.S., et al. (2025) Adiposity-Related Anthropometrics and Clinical Outcomes in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. JACC, 86, 1760-1777. [Google Scholar] [CrossRef] [PubMed]
[12] Thomas, E., Gupta, P.P., Fonarow, G.C. and Horwich, T.B. (2018) Bioelectrical Impedance Analysis of Body Composition and Survival in Patients with Heart Failure. Clinical Cardiology, 42, 129-135. [Google Scholar] [CrossRef] [PubMed]
[13] Mendonça, D.D., da Silva, W.V.R., Souza, G.C., Rados, D.V. and Biolo, A. (2025) Body Composition and Survival in Patients with Heart Failure. JACC: Heart Failure, 13, 943-954. [Google Scholar] [CrossRef] [PubMed]
[14] Konishi, M., Akiyama, E., Matsuzawa, Y., Sato, R., Kikuchi, S., Nakahashi, H., et al. (2021) Prognostic Impact of Muscle and Fat Mass in Patients with Heart Failure. Journal of Cachexia, Sarcopenia and Muscle, 12, 568-576. [Google Scholar] [CrossRef] [PubMed]
[15] Uchida, S., Kamiya, K., Hamazaki, N., Nozaki, K., Ichikawa, T., Yamashita, M., et al. (2023) Prognostic Utility of Skeletal Muscle Mass Metrics in Patients with Heart Failure. Canadian Journal of Cardiology, 39, 1630-1637. [Google Scholar] [CrossRef] [PubMed]
[16] Huynh, K., Ayers, C., Butler, J., Neeland, I., Kritchevsky, S., Pandey, A., et al. (2022) Association between Thigh Muscle Fat Infiltration and Incident Heart Failure. JACC: Heart Failure, 10, 485-493. [Google Scholar] [CrossRef] [PubMed]
[17] Savji, N., Meijers, W.C., Bartz, T.M., Bhambhani, V., Cushman, M., Nayor, M., et al. (2018) The Association of Obesity and Cardiometabolic Traits with Incident HFpEF and HFrEF. JACC: Heart Failure, 6, 701-709. [Google Scholar] [CrossRef] [PubMed]
[18] Li, M., Liang, Y., Wu, B., Zhu, Z., Wang, M., Chen, J., et al. (2025) Sex-Specific Prognostic Utility of the Sarcopenia Index in All-Cause Mortality Risk for Patients with Heart Failure. Frontiers in Nutrition, 12, Article ID: 1472596. [Google Scholar] [CrossRef] [PubMed]
[19] Katano, S., Honma, S., Nagaoka, R., Numazawa, R., Yamano, K., Fujisawa, Y., et al. (2022) Anthropometric Parameters-Derived Estimation of Muscle Mass Predicts All-Cause Mortality in Heart Failure Patients. ESC Heart Failure, 9, 4358-4365. [Google Scholar] [CrossRef] [PubMed]
[20] Wu, H. and Ballantyne, C.M. (2017) Skeletal Muscle Inflammation and Insulin Resistance in Obesity. Journal of Clinical Investigation, 127, 43-54. [Google Scholar] [CrossRef] [PubMed]
[21] Zhang, Q., Tai, S. and Zhou, S. (2024) Abdominal Obesity Is Associated with Increased Worsening Renal Function Risk in Patients with Heart Failure with Preserved Ejection Fraction. BMC Cardiovascular Disorders, 24, Article No. 477. [Google Scholar] [CrossRef] [PubMed]
[22] Sunaga, A., Hikoso, S., Yamada, T., Yasumura, Y., Uematsu, M., Abe, H., et al. (2021) Abdominal Obesity, and Not General Obesity, Is Associated with a Lower 123I MIBG Heart-to-Mediastinum Ratio in Heart Failure Patients with Preserved Ejection Fraction. European Journal of Nuclear Medicine and Molecular Imaging, 49, 609-618. [Google Scholar] [CrossRef] [PubMed]
[23] Sorimachi, H., Obokata, M., Takahashi, N., Reddy, Y.N.V., Jain, C.C., Verbrugge, F.H., et al. (2021) Pathophysiologic Importance of Visceral Adipose Tissue in Women with Heart Failure and Preserved Ejection Fraction. European Heart Journal, 42, 1595-1605. [Google Scholar] [CrossRef] [PubMed]
[24] Kenchaiah, S., Ding, J., Carr, J.J., Allison, M.A., Budoff, M.J., Tracy, R.P., et al. (2021) Pericardial Fat and the Risk of Heart Failure. Journal of the American College of Cardiology, 77, 2638-2652. [Google Scholar] [CrossRef] [PubMed]
[25] Antoniades, C., Tousoulis, D., Vavlukis, M., Fleming, I., Duncker, D.J., Eringa, E., et al. (2023) Perivascular Adipose Tissue as a Source of Therapeutic Targets and Clinical Biomarkers. European Heart Journal, 44, 3827-3844. [Google Scholar] [CrossRef] [PubMed]
[26] Rao, V.N., Fudim, M., Mentz, R.J., Michos, E.D. and Felker, G.M. (2020) Regional Adiposity and Heart Failure with Preserved Ejection Fraction. European Journal of Heart Failure, 22, 1540-1550. [Google Scholar] [CrossRef] [PubMed]
[27] Rao, V.N., Bush, C.G., Mongraw‐Chaffin, M., Hall, M.E., Clark, D., Fudim, M., et al. (2021) Regional Adiposity and Risk of Heart Failure and Mortality: The Jackson Heart Study. Journal of the American Heart Association, 10, e020920. [Google Scholar] [CrossRef] [PubMed]
[28] Huang, R., Wang, Z., Chen, J., Bao, X., Xu, N., Guo, S., et al. (2022) Prognostic Value of Triglyceride Glucose (TyG) Index in Patients with Acute Decompensated Heart Failure. Cardiovascular Diabetology, 21, Article No. 88. [Google Scholar] [CrossRef] [PubMed]
[29] Zheng, H., Chen, G., Wu, K., Wu, W., Huang, Z., Wang, X., et al. (2023) Relationship between Cumulative Exposure to Triglyceride-Glucose Index and Heart Failure: A Prospective Cohort Study. Cardiovascular Diabetology, 22, Article No. 239. [Google Scholar] [CrossRef] [PubMed]
[30] Fan, Y., Ye, D., Zhou, K., Cai, L. and Yu, L. (2025) The Novel Triglyceride-Glucose-Weighted Adjusted Waist Index as a Supplementary Diagnostic Tool for Heart Failure: Evidence of Improved Reclassification Beyond Traditional Tyg-Related Indices from a Cross-Sectional Study. Cardiovascular Diabetology, 24, Article No. 329. [Google Scholar] [CrossRef] [PubMed]
[31] Luo, X. and Cai, B. (2024) Association between Cardiometabolic Index and Congestive Heart Failure among US Adults: A Cross-Sectional Study. Frontiers in Cardiovascular Medicine, 11, Article ID: 1433950. [Google Scholar] [CrossRef] [PubMed]
[32] Neeland, I.J., Yokoo, T., Leinhard, O.D. and Lavie, C.J. (2021) 21st Century Advances in Multimodality Imaging of Obesity for Care of the Cardiovascular Patient. JACC: Cardiovascular Imaging, 14, 482-494. [Google Scholar] [CrossRef] [PubMed]
[33] Souza, A.C.d.A.H., Rosenthal, M.H., Moura, F.A., Divakaran, S., Osborne, M.T., Hainer, J., et al. (2024) Body Composition, Coronary Microvascular Dysfunction, and Future Risk of Cardiovascular Events Including Heart Failure. JACC: Cardiovascular Imaging, 17, 179-191. [Google Scholar] [CrossRef] [PubMed]
[34] Jeon, K., Hur, T., Yoon, M., Cho, H., Chun, E.J., Kim, J., et al. (2025) Novel Approach to Acute Heart Failure Risk Stratification Using AI-Derived Congestion Index from Chest Radiographs and Clinical Parameter. In: Househ, M.S., Tariq, Z.U.A., Al-Zubaidi, M., Shah, U. and Huesing, E., Eds., Studies in Health Technology and Informatics, IOS Press, 1888-1889. [Google Scholar] [CrossRef] [PubMed]
[35] Smichi, N., Khatua, B., Kostenko, S., de Oliveira, C., El Kurdi, B., Devani, K.H., et al. (2025) Visceral Fat Lipolysis by Pancreatic Lipases Worsens Heart Failure. Cell Reports Medicine, 6, Article 102147. [Google Scholar] [CrossRef] [PubMed]
[36] Neeland, I.J., Winders, B.R., Ayers, C.R., Das, S.R., Chang, A.Y., Berry, J.D., et al. (2013) Higher Natriuretic Peptide Levels Associate with a Favorable Adipose Tissue Distribution Profile. Journal of the American College of Cardiology, 62, 752-760. [Google Scholar] [CrossRef] [PubMed]
[37] Dronkers, J., van Veldhuisen, D.J., van der Meer, P. and Meems, L.M.G. (2024) Heart Failure and Obesity. Journal of the American College of Cardiology, 84, 1666-1677. [Google Scholar] [CrossRef] [PubMed]
[38] Piché, M., Poirier, P., Lemieux, I. and Després, J. (2018) Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update. Progress in Cardiovascular Diseases, 61, 103-113. [Google Scholar] [CrossRef] [PubMed]

为你推荐